arrow
É

Éric Deutsch

INSERM
H指数:74
被引数:3.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Context-Dependent Radioenhancement by Platinum Nanoparticles Under Conventional and Ultra-High Dose-Rate “FLASH” Radiotherapy

铂纳米粒子在常规及超高剂量率“FLASH”放射治疗下的条件依赖性放射增强

Small
IF12.1
2026-10-010
OAAI
Development and external validation of a prognostic score associated with poor outcomes in patients receiving immune checkpoint blockade-containing therapies enrolled in early-phase clinical trials

基于早期临床试验中接受免疫检查点阻断治疗患者的预后评分的开发与外部验证:与不良结局相关的评分

2026-07-010
PRE
Metabolic determinants of cancer immunotherapy outcomes identified by plasma profiling

通过血浆谱分析确定的癌症免疫治疗结果的代谢决定因素

2026-06-250
OAAI
Single cells and spatial RNA profiling reveal that inflammatory fibroblasts arise from Edil3 stromal cells in the colon after irradiation

单细胞和空间RNA分析揭示辐射后结肠中炎症成纤维细胞源自Edil3基质细胞

2026-06-090
PRE
Radioenhancing Hafnium Oxide Nanoparticles (NBTXR3) Followed by Stereotactic Body Radiation Therapy in Patients With Hepatocellular Carcinoma and Liver Metastases (NBTXR3-103): Phase 1 Dose-Escalation Trial

放射增敏氧化铪纳米颗粒(NBTXR3)后联合立体定向体放射疗法治疗肝细胞癌和肝转移患者(NBTXR3-103):1期剂量递增试验

2025-12-010
OA
Validation of DICOM extraction and Structuration Toolkit (DEST) for automated extraction and structuration of radiotherapy data for large-scale analysis

DICOM Extraction and Structuration Toolkit(DEST)的验证:用于大规模分析的放射治疗数据自动提取与结构化

2025-11-150
PRE
RadioTransNet: Preclinical research network coordinated by the Société franc,aise de radiothérapie oncologique and Société franc,aise de physique médicale, 2025 update

RadioTransNet:由Société française de radiothérapie oncologique和Société française de physique médicale协调的前临床研究网络,2025年更新

2025-11-010
PRE
Updates on radiotherapy-immunotherapy combinations: Proceedings of 8th Annual ImmunoRad Conference

放射治疗-免疫治疗联合疗法的最新进展:第8届年度免疫放射大会会议录

2025-05-220
OAAI
Enhancing radiotherapy with PARP inhibition in soft-tissue sarcomas: a promising synergy requiring specific attention to normal tissues?

增强软组织肉瘤的放射治疗与PARP抑制:一种有前景的协同作用,是否需要特别关注正常组织?

2025-02-010
PRE